Datharsis (Explain Tech S.L.) is a deep tech spin-off of the University of Granada, Spain, specialised in the explainable analysis of omics data across the life sciences, from health to agri-food and ecology. We help research teams design their studies and turn high-dimensional, noisy and multimodal data into traceable, reproducible evidence.
Scientific foundation. Our methods come from twenty years of peer-reviewed research at the Computational Data Science Laboratory (CoDaS Lab) of the University of Granada, and we use them under an exclusive commercial licence from the university. Our Chief Scientific Advisor, Prof. José Camacho, is a Full Professor at the University of Granada, head of CoDaS Lab and ranked in Stanford's top 2% of scientists worldwide. He leads our scientific strategy and our participation in European research projects.
Two things we do:
Statistical design of experiments. Many studies fail not in the analysis but in the design. Before any sample is collected, we help define the questions the study must answer, the factors and interactions to include, the sampling strategy and the sample size needed, using our own computational methods. The result is more statistical power with fewer samples, and lower field, laboratory and sequencing costs. In a Horizon Europe proposal, this strengthens the methodology section from the start.
Interpretable analysis and integration of omics data. We integrate omics layers (metabolomics, proteomics, transcriptomics, epigenomics, microbiota, spatial omics) with clinical, spectral or environmental data. Our models are interpretable by design, not explained afterwards with post-hoc layers. Methods developed by our team, such as vASCA, group-wise models and MEDA, reveal which variables drive each effect in experiments with several crossed factors. Cross-validation and permutation testing then confirm that the results are robust and not artefacts. See the scientific evidence.
Our team's methods have been applied to:
Response to chemotherapy and survival signatures in cancer, using metabolomics
Multi-omics profiling of a paediatric cohort, combining microbiota, metabolomics and clinical data
The spread of a mycotoxin in wheat varieties over the crop cycle
Food authentication and traceability
The effect of mistletoe parasitism on the pine metabolome, separated from season, tree and canopy height
The effect of contaminants across three tissues of crabs in ecotoxicology studies
Warming trends in high mountain lakes, separating the shared climate signal from the features of each lake
These are only some examples. The same methods work wherever data combine several factors, many variables and few samples, and our team has also applied them to volcanic eruption forecasting, industrial process monitoring and network security. See all documented cases.
What we bring to a consortium:
Leadership of the data analysis work package, or of specific analysis tasks
Study design and sample size planning, from the proposal stage
Discovery of interpretable biomarkers, indicators and signatures, with rigorous statistical validation
Reproducible, auditable analysis pipelines aligned with FAIR principles
DathaSuite, our analysis platform, so consortium researchers can explore their own data with the same methods
Training of consortium researchers through our DathaXplain programme
If your project will generate complex omics data and needs results that hold up before reviewers and regulators, let's talk.
Omics data analysis partner for One Health research: study design, integration of microbiota, metabolomics and other omics with clinical and environmental data, and interpretable, validated models.
Early stage
Advanced stage
Partner looking for consortium
HORIZON-NATURE-2027-03-01: Advancing interdisciplinary, data-driven research at the biodiversity- health interface under a One Health approach
Omics and multifactor analysis partner to separate the effects of PFAS, industrial activity and other pressures (dose, time, species, tissue, site) on organisms and biodiversity, with interpretable models and study design.
Early stage
Advanced stage
Partner looking for consortium
HORIZON-NATURE-2027-02-01: Assessing direct and indirect drivers of biodiversity decline of invertebrates
HORIZON-NATURE-2027-01-01: Understanding the nature and the extent of the effects of PFAS on biodiversity and ecosystem services
HORIZON-NATURE-2027-01-02: Better understanding, anticipating and addressing the biodiversity benefits and impacts of the clean and digital industries
Statistical study design partner for cost-effective biodiversity monitoring: how many samples, where and when to take them, and interpretable analysis of multi-site, multi-season and omics data.
Early stage
Advanced stage
Partner looking for consortium
HORIZON-NATURE-2027-02-05: Cost-effective biodiversity monitoring for EU policies
HORIZON-NATURE-2027-02-01: Assessing direct and indirect drivers of biodiversity decline of invertebrates
HORIZON-NATURE-2027-02-04: Innovative solutions to fight wildlife trafficking and to reduce invasion of invasive alien species
Data analysis partner for species identification and origin authentication: interpretable, validated classification models on omics and spectral fingerprints, and study design for reference sample collections.
Early stage
Advanced stage
Partner looking for consortium
HORIZON-NATURE-2027-02-04: Innovative solutions to fight wildlife trafficking and to reduce invasion of invasive alien species